Dimensionally stable and growth controlled inflatable member for a catheter
A dimensionally stable and growth controlled inflatable member formed by adding a multifunctional agent to a soft polymer to form a compound, extruding an inflatable member from the compound, and crosslinking the compound. The inflatable member is configured to be formed-in-place with a body lumen. Preferably, the inflatable member is blown to a working diameter prior to use and then heated to the glass transition temperature of the polymer to shrink the diameter of the blown inflatable member back to about the nominal diameter of the tubing. In another embodiment, the invention is a dimensionally stable and growth controlled inflatable member comprising longitudinal zones of crosslinked material symmetrically spaced about the circumference of the inflatable member and a uniform working diameter. Preferably, there are three or more longitudinal zones that run the working length of the inflatable member. The selectively irradiated inflatable members are formed in a mold having symmetrically spaced longitudinal windows.
Latest Advanced Cardiovascular Systems, Inc. Patents:
This invention generally relates to the field of medical devices, and particularly to a catheter balloon formed at least in part of a crosslinked material.
In the design of balloons for catheters, and particularly angioplasty catheters, important considerations include controlling the expanded dimensions of the balloon and obtaining acceptable rupture characteristics. Further, the characteristics generally must be weighed against the softness, or feel, of the balloon. Although a soft feel can be desirable, compliance must be regulated to maintain sufficient control over balloon dimension. Likewise, acceptable rupture characteristics are critical to minimize the risk of catastrophic balloon failure.
Prior art techniques for producing balloons from soft materials with acceptable balloon rupture characteristics and low compliance have blow molded the balloons using high blow up ratios (BURs). The BUR is defined as the outer diameter of the balloon divided by the inner diameter of the balloon tubing used to form the balloon. One difficulty has been that polymer films have a limited biaxial stretch ratio beyond which the films suffer from defects such as microtears. Thus, balloons formed from softer materials that have been imbued with controlled radial growth through the use of high BURs must therefor not experience excessive axial stretching during formation or inflation. This typically results in a tradeoff between axial growth and radial growth in softer materials.
Control over these characteristics is especially important when designing formed-in-place balloons. In these catheters, the balloon is expanded within the patient's vessel from its nominal diameter, rather than introduced into the patient's vasculature as a deflated balloon formed by blow molding. Safety considerations require that these balloons be capable of reaching their rated nominal diameter at relatively low pressure, preferably less than about 15 atmospheres (atm). Thus, formed-in-place balloons must be compliant up to the desired working diameter and exhibit minimal compliance beyond the working diameter. Without these characteristics, the risk of damage to the vessel due to over expansion is considerable. EP 540858A1 discloses a method of making a formed-in-place balloon having elastic expansion within a limited pressure range, in which the balloon tubing is subjected to a heat treatment before being expanded and heat shrunk to the balloon tubing diameter to form the balloon.
Accordingly, there is a need for catheter balloons that offer improved dimensional stability. It would be a significant advance to provide balloons with improved radial compliance to a working diameter and low compliance beyond that dimension, and balloons that are configured to prevent excessive axial growth upon inflation. There is a corresponding need for balloon fabrication techniques that produce balloons having these characteristics. This invention satisfies these and other needs.
SUMMARY OF THE INVENTIONThe invention is generally directed to dimensionally stable and growth controlled inflatable members for use with a catheter.
One embodiment comprises an inflatable member formed by the process comprising adding a multifunctional agent to a soft polymer to form a compound, extruding or otherwise forming an inflatable member from the compound, and cross-linking the compound of the extruded inflatable member. The inflatable member exhibits radial compliance to a desired working diameter within a first pressure range, and lower radial compliance above the first pressure range. Preferably, the resulting inflatable member exhibits radial compliance at inflation pressures of less than about 20 atm to a desired working diameter. The inflatable member is configured to be formed-in-place with a body lumen. Since the inflatable member retains its nominal balloon tubing diameter until it is inflated, catheters equipped with these inflatable members have relatively small profiles, facilitating insertion and the crossing of lesions. By tailoring the choice of polymer, the blend of multifunctional additive, and the amount of crosslinking, inflatable member can be configured to exhibit a desired compliance as it is blown through a pressure range from the nominal diameter of the tubing to its desired working diameter. However, once the working diameter is achieved, the crosslinking acts to restrain further radial growth. This helps prevent the inflatable member from causing damage to the body lumen by being overexpanded inadvertently. The invention also comprises the method for forming such inflatable members. The invention may further comprise such inflatable members that have been blown to the desired working diameter before being placed in the body lumen, and then heated to an elevated temperature, which in a presently preferred embodiment is the glass transition temperature of the polymer, to shrink the diameter of the blown inflatable member back to about the nominal diameter of the tubing for positioning and inflation within the body lumen. Upon reinflation within the body lumen, it reaches its nominal or working diameter at pressures less than, and preferably significantly less than the rated burst pressure of the inflatable member.
Another embodiment is directed to an inflatable member having zones of stiffening material spaced about the circumference of at least a section of the inflatable member. The zones generate an inflatable member that exhibits low axial compliance. Specifically, the zones have a higher modulus than the non-crosslinked portions of inflatable member, and limit axial growth of the inflatable member during inflation thereof without significantly affecting radial expansion. The stiffening zones expand with adjacent portions of the balloon such that the balloon section expands to a substantially cylindrical configuration. In one embodiment, the stiffening zones comprise polymeric material coextruded as a layer of the balloon, wherein the zones are coextruded onto a balloon formed of a softer material than the zones. In another embodiment, the stiffening zones comprise crosslinked polymeric material. In a presently preferred embodiment, the zones extend within only the working length of the inflatable member. However, in other embodiments, the zones may extend over less than the working length or over the entire length of the inflatable member. In one embodiment, the zones are longitudinally extending stripes axially aligned with the longitudinal axis of the inflatable member. However, the zones may have a variety of suitable configurations. Preferably, there are three or more zones.
One embodiment comprises a method for forming inflatable members with longitudinal crosslinked zones generally comprising blending a soft polymer with a multifunctional agent to form a compound, extruding or otherwise forming a tubular member, or parison, from the compound, blowing the parison into the inflatable member in a mold having longitudinal windows transparent to the crosslinking radiation, and crosslinking the compound with radiation. Alternatively, the parison can be blown in a conventional mold and then reinflated in a second mold having longitudinal windows for crosslinking. In another embodiment, the method comprises providing an inflatable member, coating the inflatable member with crosslinkable material, selectively radiating or otherwise crosslinking longitudinal zones of the inflatable member, preferably by inflating the inflatable member in a mold having longitudinal windows transparent to crosslinking radiation, and then radiating the coated inflatable member. In certain embodiments, it may be desirable to remove the multifunctional agent from the areas of the inflatable member that are not exposed to radiation.
The terminology “soft polymers” used herein should be understood to mean polymers having a tensile modulus of typically less than about 125,000 psi, and preferably less than about 75,000 psi. Typically, the soft polymers used in the invention comprise polymers having a glass transition temperature of about 20° C. to about 60° C., and more specifically up to about 37° C. to about 40° C. Suitable polymers exhibit a relatively low flexural or tensile modulus, a relatively high tensile strength of not less than about 4000 psi, and a relatively high elongation to break of greater than about 200%. The Shore durometer hardness of the soft polymer is typically not greater than about 70D. Specific examples include polyamide-ether block copolymer (PEBAX), polyether-ester block copolymer, polyester-ester block copolymer, polyester-urethane block copolymer, polyolefin, polyolefin block copolymer, polyether-urethane block copolymer, polycarbonate-urethane copolymer, polyether-urethane, ethylene copolymers, polydimethyl siloxane (poly DMS), polysiloxanes and their block copolymers, vinylidene fluoride copolymers, EPDM, Santoprene, Kraton, and Viton. Absent the multifunctional agent, these soft polymers would not crosslink appreciably when exposed to crosslinking radiation, excepting polymers such as ethylene containing polymers including polyolefins which are crosslinkable by e-beam or gamma radiation. Preferably, the multifunctional agents include monomers and oligomers known in the art as crosslinking agents. Specific examples include multifunctional acrylates, vinylics, acetylenics, photopolymers, trimethylolpropane triacrylate (TMPTA), tripropyleneglycol diacrylate (TPGDA), triallyl cyanurate (TAC), triallyl isocyanurate (TAIC) and N,N′-m-phenylenediamaleimide.
The invention provides catheter balloons with a desired softness and improved expansion characteristics due to crosslinking or coextrusion which provides for controlled axial or radial expansion. These and other advantages will become more apparent from the following detailed description and exemplary figures.
To optimize the performance of inflatable member 10, it may be desirable to blow the crosslinked tubing to its working diameter prior to use in a patient. The tubing is blown in a mold similar to mold 16 illustrated in FIG. 3 and discussed below, except without longitudinally extending windows 18. The expanded inflatable member then may be heated to the glass transition temperature of the polymer to cause it to return to the nominal diameter of the tubing. This process can be repeated if necessary to condition the inflatable member so that it reliably blows to the desired working diameter and shape. The shape of the tubing can also be specially shaped, such as by selectively altering the wall thickness, to improve the blowing characteristics.
In an alternative embodiment illustrated in
Mold 16 or 20 with inflated inflatable member 12 is exposed to crosslinking radiation either by rotating the mold in front of the radiation source or by employing a circular radiation source to ensure that each window 18 is evenly irradiated. An alternative method of forming inflatable member 12 includes blowing the tubing in a conventional mold, deflating the inflatable member and placing it in mold 16 or 20. Inflatable member 12 then is reinflated and selectively exposed to crosslinking radiation through apertures or windows 18.
Longitudinal zones 14 are circumferentially spaced about the inflatable member, and in a presently preferred embodiment are symmetrically spaced about the circumference of inflatable member 12. The crosslinked zones radially inflate with the noncrosslinked portions of the inflatable member at least up to the working diameter, so that a generally cylindrical shape is formed upon inflation, with a uniform working diameter along the working length of the inflatable member, as illustrated in
In the alternative embodiment shown in
In the embodiment illustrated in
In the selectively irradiated embodiments, it may be desirable to remove the multifunctional agent from the non-crosslinked portions of the inflatable member, as many multifunctional agents can pose a health risk due to their toxicity. The multifunctional agents can be removed by selective solvent extraction, supercritical CO2 extraction, or other suitable methods. If the multifunctional agent does not pose a health risk, there is generally no need to remove it.
Preferably, the soft polymers used in the invention comprise polymers having a glass transition temperature of about 20° C. to about 60° C. and more preferably up to about 37° C. to about 40° C. Specific examples include polyamide-ether block copolymer, polyether-ester block copolymer, polyester-ester block copolymer, polyester-urethane block copolymer, polyolefin, polyolefin block copolymer, polyether-urethane block copolymer. Generally, polyolefins which don't require a crosslinking agent and which lack sufficient strength for high pressure thin-walled balloons are not preferred for the formed-in-place embodiments, and polyamides are not preferred for the selectively irradiated embodiments. Suitable polymers exhibit a relatively high tensile strength of about 4000 psi to about 8000 psi, a relatively low flexural modulus of about 20,000 psi to about 75,000 psi, and a high elongation of about 300% to about 1000%, more specifically about 200% to about 500%, and preferably about 300% to about 400%. In one embodiment, the Shore durometer hardness of the polymer is about 50A to about 70D, and preferably about 60A to about 65D.
In some embodiments of the invention, it may be desirable to tailor the polymer and multifunctional agent compounds to foster crosslinking in the multifunctional material alone to form a semi-interpenetrating network (SIPN). An interpenetrating network allows the preparation of molecularly homogeneous mixtures of poorly soluble polymers. So long as the crosslinking reaction is carried out relatively quickly, the S-IPN prevents phase separation of the polymers into large domains. It is desirable to prevent phase separation as domains greater than 5 microns could act as defect points and degrade rupture and fatigue performance.
Preferably, the multifunctional agents include monomers and oligomers known in the art as crosslinking agents. Specific examples include trimethylolpropane triacrylate (TMPTA) and trimethacrylate (TMPTMA), tripropyleneglycol diacrylate (TPGDA), triallyl cyanurate (TAC), triallyl isocyanurate (TAlC), N,N′-m-phenylenediamaleimide, and trivinyl benzene.
The presently preferred radiation producing the crosslinking reaction is electron beam radiation, at a radiation dose level of about 2 Mrad to about 50 Mrad, although other suitable types of radiation, such as UV or gamma radiation may be used. Windows 18 of the mold should be configured to be substantially transparent to the type of radiation being used. Substantially transparent should be understood to mean the window should allow for greater than about 50%, preferably greater than about 70% of the radiation to pass through the window. During radiation curing of polymers, there can be competition between the desirable crosslinking reaction and oxidative chain scission. Chain scission leads to embrittlement and a loss of the growth control and dimensional stability characteristics of the invention. Accordingly, it may be desirable to add suitable antioxidants to the compounds to prevent chain scission.
While the present invention has been described herein in terms of certain preferred embodiments, modifications may be made without departing from the scope of the invention. Although individual features of embodiments of the invention may be described or shown in some of the drawings and not in others, those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of another embodiment.
Claims
1. A balloon catheter, comprising
- a) an elongated catheter shaft; and
- b) a selectively crosslinked balloon on a distal portion of the shaft, having non-crosslinked portions, and radially spaced, longitudinally extending stiffening zones of crosslinked material along at least a section of the balloon, wherein the stiffening zones expand with adjacent portions of the balloon such that the balloon expands to a substantially cylindrical configuration.
2. The balloon catheter of claim 1 wherein the longitudinally extending stiffening zones comprise a polymeric material coextruded as an intermittent first layer of the balloon, wherein the stiffening zone polymeric material has a higher Shore durometer hardness than a polymeric material forming a second layer of the balloon.
3. The balloon catheter of claim 1, wherein the balloon comprises a polymer having a glass transition temperature of about 20° C. to about 60° C.
4. The balloon catheter of claim 3, wherein the polymer is selected from the group consisting of polyamide-ether block copolymer, polyether-ester block copolymer, polyester-ester block copolymer, polyester-urethane block copolymer, polyether-urethane block copolymer, polycarbonate-urethane block copolymer, polyolefin, and polyolefin block copolymer.
5. The balloon catheter of claim 1 wherein the longitudinally extending stiffening zones are symmetrically spaced and configured to control axial growth of the balloon during inflation thereof.
6. The balloon catheter of claim 1 wherein the stiffening zones define in part an outer most edge of the expanded balloon.
4113594 | September 12, 1978 | Nyberg |
4444816 | April 24, 1984 | Richards et al. |
4456000 | June 26, 1984 | Schjeldahl et al. |
4871810 | October 3, 1989 | Saltman |
5091478 | February 25, 1992 | Saltman |
5108370 | April 28, 1992 | Walinsky |
5250228 | October 5, 1993 | Baigrie et al. |
5312356 | May 17, 1994 | Engelson et al. |
5317061 | May 31, 1994 | Chu et al. |
5318587 | June 7, 1994 | Davey |
5382384 | January 17, 1995 | Baigrie et al. |
5397307 | March 14, 1995 | Goodin |
5456666 | October 10, 1995 | Campbell et al. |
5458572 | October 17, 1995 | Campbell et al. |
5470314 | November 28, 1995 | Walinsky |
5478319 | December 26, 1995 | Campbell et al. |
5484411 | January 16, 1996 | Inderbitzen et al. |
5554120 | September 10, 1996 | Chen et al. |
5565523 | October 15, 1996 | Chen et al. |
5733496 | March 31, 1998 | Avellanet |
5747591 | May 5, 1998 | Chen et al. |
5759172 | June 2, 1998 | Weber et al. |
5792300 | August 11, 1998 | Inderbitzen et al. |
5797877 | August 25, 1998 | Hamilton et al. |
5849846 | December 15, 1998 | Chen et al. |
6013728 | January 11, 2000 | Chen et al. |
6024722 | February 15, 2000 | Rau et al. |
6086556 | July 11, 2000 | Hamilton et al. |
6090099 | July 18, 2000 | Samson et al. |
6129706 | October 10, 2000 | Janacek |
6190357 | February 20, 2001 | Ferrari et al. |
6270522 | August 7, 2001 | Simhambhatla et al. |
6336936 | January 8, 2002 | Simhambhatla et al. |
6428506 | August 6, 2002 | Simhambhatla et al. |
6592550 | July 15, 2003 | Boatman et al. |
6596818 | July 22, 2003 | Zamore |
20020077418 | June 20, 2002 | Chen et al. |
20010027329 | October 4, 2001 | Simhambhatla et al. |
20020062133 | May 23, 2002 | Gilson et al. |
20020103455 | August 1, 2002 | Zhang et al. |
0 540 858 | May 1993 | EP |
0 669 143 | August 1995 | EP |
0 737 488 | October 1996 | EP |
0 872 258 | October 1998 | EP |
WO 9517223 | June 1995 | WO |
Type: Grant
Filed: Nov 14, 2000
Date of Patent: Apr 5, 2005
Assignee: Advanced Cardiovascular Systems, Inc. (Santa Clara, CA)
Inventors: Murthy V. Simhambhatla (San Jose, CA), Robert P. Saltman (Redwood City, CA)
Primary Examiner: Henry Bennett
Assistant Examiner: Andrea M. Ragonese
Attorney: Fulwider Patton Lee & Utecht LLP
Application Number: 09/713,384